A Phase II Study of Recombinant Human Interferon-α2a and Zidovudine in Patients with AIDS-Related Kaposi's Sarcoma

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 4, 1996, Pages 379-384

  Fischl, Margaret A ^a   Finkelstein, Dianne M ^b   He, Weili ^b   Powderly, William G ^c   Triozzi, Pierre L ^d   Steigbigel, Roy T ^e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

Interferon ; Kaposi's sarcoma; Zidovudine

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON ALFA-2A; MALE; SARCOMA, KAPOSI; SURVIVAL RATE; ZIDOVUDINE;

EID: 0029989578     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199604010-00008     Document Type: Article

References (28)

1. Krown SE, Real FX, Cunningham-Rundles S, et al. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 1983;308:1071-6.
2. Groopman JE, Gottlieb MS, Goodman J, et al. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:671-6.
3. Krown SE, Real FX, Krim M, et al. Recombinant leukocyte A interferon in Kaposi's sarcoma. Ann NY Acad Sci 1984; 437:431-8.
4. Volberding PA, Valera R, Rothman J, Gee G. Alpha interferon therapy of Kaposi's sarcoma in AIDS. Ann NY Acad Sci 1984;437:439-46.
5. Rios A, Mansell PW, Newell GR, Reuben JM, Hersh EM, Gutterman JU. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma with lymphoblastoid interferon. J Clin Oncol 1985;3:506-12.
6. Gelmann EP, Preble OT, Steis R, et al. Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Clinical response and prognostic parameters. Am J Med 1985;78:737-41.
7. Krown SE, Real FX, Vadhan-Rays, et al. Kaposi's sarcoma and the Acquired Immune Deficiency Syndrome: Treatment with recombinant interferon alpha and analysis of prognostic factors. Cancer 1986;57:1162-5.
8. Real FX, Oettgen HF, Krown, SE. Kaposi's sarcoma and the acquired immunodeficiency syndrome. Treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 1986;4:544-51.
9. Abrams DI, Volberding PA. Alpha interferon therapy and AIDS-associated Kaposi's sarcoma. Semin Oncol 1986;14:(2 Suppl 2)43-7.
10. Volberding PA, Mitsuyasu RT, Golando JP, Spiegel RJ. Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A). Cancer 1987;59:620-5.
11. de Wit R, Schatenkerk JK, Boucher CB, et al. Clinical virological effects of high-dose recombinant interferon-α in disseminated AIDS-related Kaposi's sarcoma. Lancet 1988; 2:1214-7.
12. Krown SE, Real FX, Lester T, Oettgen HF. Interferon alfa-2a (IFN-α 2a) ± vinblastine (VLB) in AIDS-related Kaposi's sarcoma (KS/AIDS). A prospective randomized trial. Proc Am Soc Clin Oncol 1986;5:6.
13. Longberg M, Odajnyk CM, Krigel R, et al. Sequential and simultaneous alpha-2 interferon (IFN) and VP16 in epidemic Kaposi's sarcoma (EKS). Proc Am Soc Clin Oncol 1985;4:2.
14. Shepherd FA, Evans WK, Garvey B, et al. Combination chemotherapy and α-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome. Can Med Assoc J 1988;139:635-9.
15. Borrleffs JCCC, van der Ende ME, van Leusen R, van 'T Wout JW. Triple therapy with vinblastine, interferon-α 2a and zidovudine for AIDS-related Kaposi's sarcoma [Letter]. J Acquir Immune Defic Synd 1991;4:1161-2.
16. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:185-91.
17. Volberding P, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322:941-9.
18. Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1(HIV) infection. Ann Intern Med 1990;112:727-37.
19. Graham NMH, Zeger SL, Park LP, et al. The effects on survival of early treatment of human immunodeficiency virus infections. N Engl J Med 1992;326:1037-42.
20. Lane HC, Fallon J, Walker Re, et al. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. Ann Intern Med 1989;111:41-50.
21. Hartshorn KL, Vogt MW, Chou TC, et al. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha-A interferon. Antimicrob Agents Chemother 1987;31:168-72.
22. Johnson VA, Merrill DP, Videler JA, et al. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro. J Infect Dis 1991;164:646-55.
23. Kovacs JA, Deyton L, Davey R, et al. Combined zidovudine and interferon-α therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;111:280-7.
24. Krown SE, Gold JWM, Niedzwiecki D, et al. Interferon-α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the aquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;112:812-21.
25. n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J Acq Immune Defic Synd 1991;4:1-10.
26. Meng TC, Fischl MA, Boota AM, et al. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1992;116:13-20.
27. Collier AC, Coombs RW, Fischl MA, et al. Combination therapy with zidovudine and didanosine compared to zidovudine alone in human immunodeficiency virus type one infection. Ann Intern Med 1993;199:786-93.
28. Mildvan D, Machado SG, Wilets I, Grossberg SE. Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992;339:453-56.